Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) saw a large growth in short interest in April. As of April 15th, there was short interest totalling 73,300 shares, a growth of 633.0% from the March 31st total of 10,000 shares. Approximately 0.0% of the company's stock are short sold. Based on an average trading volume of 192,200 shares, the days-to-cover ratio is currently 0.4 days.
Sysmex Stock Down 0.7 %
Shares of SSMXY stock traded down $0.14 during trading on Friday, reaching $18.59. The company's stock had a trading volume of 23,626 shares, compared to its average volume of 70,018. The business has a fifty day moving average price of $18.57 and a 200-day moving average price of $18.94. Sysmex has a one year low of $14.38 and a one year high of $22.00. The company has a quick ratio of 2.42, a current ratio of 3.19 and a debt-to-equity ratio of 0.11. The company has a market cap of $11.70 billion, a price-to-earnings ratio of 36.87 and a beta of 1.08.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its earnings results on Wednesday, February 12th. The company reported $0.17 earnings per share (EPS) for the quarter. Analysts anticipate that Sysmex will post 0.57 earnings per share for the current year.
Sysmex Company Profile
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
